ABT

ABT

Abbott's Third Quarter Results: A New Era of Growth and Innovation

In a highly anticipated conference call, Abbott reported its third quarter results for 2026, marking an important milestone in the company's history. At the center of the announcement was the decision to separate its nutrition business into an independent, publicly traded company. Underpinning this strategic move is the

ABT

Abbott Accelerates Growth Momentum with Strong Q2 Results

Abbott, a leading global healthcare company, has reported impressive second quarter 2026 earnings, with sales growth accelerating to 4.8% and adjusted earnings per share exceeding expectations at $1.31. The company's Chairman and Chief Executive Officer, Robert Ford, highlighted several key pipeline achievements during the conference call,